GE HealthCare Technologies Inc. Common Stock
Here’s whether GE HealthCare Technologies Inc. Common Stock (GEHC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.06% over 10 days); 3-month momentum positive (+16.5%). Concerns: RSI 74 — overbought, elevated pullback risk; declining volume on rally — weak conviction (0.52x 30d avg). Currently 16.6% off its 52-week high. Score: +3/7.
GEHC is in a confirmed uptrend, trading above both its 50-day ($66.66) and 200-day ($72.84) moving averages. With an RSI of 74.5, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +2.3% compares to +20.5% for SPY (trailed the market by 18.2%).